Brief: NovelStem Increases NewStem Ownership To 33%, Prepares For FDA Filing For Approval Of Its Stem-Cell Based Anti-Cancer Drug Resistance Diagnostic01/12/2020 13:38
Last trade - 00:00Last trade - 00:00Last trade - 00:00